Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Benyam Muluneh"'
Autor:
Benyam Muluneh, Michele A Muir, James Bernard Collins, Darrian Proco, Emily Mackler, Ashley Leak Bryant, William A Wood, Michael Tilkens, Jeffrey S Reichard, Matthew Foster, Justin Gatwood, Stephanie B Wheeler, Leah L Zullig, Jennifer Elston Lafata
Publikováno v:
PLoS ONE, Vol 18, Iss 7, p e0286630 (2023)
PurposeThe goal of this study is to determine barriers and facilitators to the implementation of medication adherence interventions to support cancer patients taking novel, targeted oral anticancer agents (OAAs).MethodsWe conducted qualitative interv
Externí odkaz:
https://doaj.org/article/fd29ebf62052481291363b91f3edfc74
Autor:
Atalay Mulu Fentie, Kaitlyn Buhlinger, Jared Borlagdan, Adam Bernstein, Sheila Weitzman, Wondwessen Bekele, David Korones, Thomas B. Alexander, Julie Broas, Aziza Shad, Ali Mamude Dinkiye, Daniel Hailu, Benyam Muluneh
Publikováno v:
Blood Advances, Vol 3, Iss , Pp 16-19 (2019)
Externí odkaz:
https://doaj.org/article/4161fb2fdcd74ddc873af2d8fc7d3717
Autor:
Shannon Palmer, Ashley Chen, Taylor Dennison, Cameron Czech, Jessica Auten, Kaitlyn Buhlinger, Benyam Muluneh
Publikováno v:
Pharmacy, Vol 9, Iss 3, p 130 (2021)
Oncology clinical pharmacists are uniquely positioned to make interventions to impact the knowledge, attitudes, and practices of clinicians as well as patient activation and engagement. To accomplish this goal, pharmacists can target health system-re
Externí odkaz:
https://doaj.org/article/125320b66771429f9e2468e824a4d0dd
Autor:
Kevin Y. Chen, Kelly M. Brunk, Bianka A. Patel, Kurtis J. Stocker, Jessica J. Auten, Kaitlyn M. Buhlinger, Benyam Muluneh
Publikováno v:
Pharmacy, Vol 8, Iss 2, p 52 (2020)
Chronic lymphocytic leukemia (CLL) is a hematologic malignancy that has seen significant advances in care over the last 5 years with the approval of oral agents such as ibrutinib and venetoclax for the treatment of this disease. As such, there has be
Externí odkaz:
https://doaj.org/article/eabfd58173114fe5b5f4b8bafebbc0bb
Autor:
Atalay Mulu Fentie, Zelalem Tilahun Mekonen, Zelalem Gizachew, Mahlet Hailemariam, Stephen M. Clark, Jaime Richardson, Benyam Muluneh
Publikováno v:
Pediatric Hematology and Oncology. 40:258-266
Optimal chemotherapy management is substandard in low and middle-income countries. We aimed to identify major gaps to design interventional strategies for improved chemotherapy management at Tikur Anbessa Specialized Hospital (TASH), Ethiopia. This s
Autor:
James B. Collins, Michele A. Muir, Emily Mackler, Ashley L. Bryant, William A. Wood, Stephanie Wheeler, Leah Zullig, Jennifer E. Lafata, Benyam Muluneh
Publikováno v:
Blood. 140:7961-7963
Autor:
Benyam, Muluneh
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:1185-1187
Autor:
Madeleine A. Ochs, Bernard L. Marini, Lydia L. Benitez, Sarah E. Stump, Taylor M. Weis, Kaitlyn M. Buhlinger, Thomas Diaz, Justin H. Reid, Benyam Muluneh, Kristen Pettit, Patrick Burke, Dale L. Bixby, Anthony J. Perissinotti
Publikováno v:
Leukemia & Lymphoma. 63:1839-1848
Patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) represent a heterogeneous population and therefore there is no standard of care first salvage regimen. We conducted a multicenter, retrospective analysis to compare chemothera
Autor:
James Collins, Sarah E. Stump, Hillary Heiling, Michele Muir, Allison Deal, Darrian Proco, Catharine Nguyen, Monica Cozad, Anthony Mato, Catherine C. Coombs, Benyam Muluneh
Publikováno v:
Leukemia & Lymphoma. 63:1823-1830
Ibrutinib is an oral Bruton's tyrosine kinase inhibitor approved for treatment of chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Clinical trial data suggest that strict adherence is directly related to clinical outcomes. Thi
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:935-944
Objective The objective of this article is to review the current supporting literature for the use of oral oncolytics in chronic lymphocytic leukemia, consideration for their use and management of adverse drug events that may limit use. Data Sources